ANTI-NEPRILYSIN MARKET ANALYSIS

Regional Analysis

Figure 2. Global Anti-Neprilysin Market Share (%), By Region, 2023

Global Anti-Neprilysin Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global anti-neprilysin market over the forecast perioddue to increasing number of R&D activities in the region. For instance, according to a report published in June 2020, by American Journal of Managed Care, an independent, peer-reviewed publication dedicated to disseminating clinical information to managed care physicians, clinical decision makers, and other healthcare professionals, inflammation and fibrosis seen in heart failure with reduced ejection fraction (HFrEF) appeared subdued following treatment with  anti-neprilysin agents.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa